These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2713295)

  • 1. Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/progestogen therapy.
    Farish E; Fletcher CD; Dagen MM; Hart DM; Al-Azzawi F; Parkin DE; Howie CA
    Br J Obstet Gynaecol; 1989 Mar; 96(3):358-64. PubMed ID: 2713295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein and apoprotein levels in postmenopausal women during treatment with norethisterone.
    Farish E; Fletcher CD; Hart DM; Dagen MM; Parkin DE
    Clin Chim Acta; 1986 Sep; 159(2):147-51. PubMed ID: 3769206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a new cyclical sequential postmenopausal HRT on lipoprotein, apoprotein and thrombophilia profile.
    Habiba M; Akkad A; al-Azzawi F
    Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):89-94. PubMed ID: 7493716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term changes in lipoproteins and apoproteins during cyclical oestrogen-progestogen replacement therapy.
    Fletcher CD; Farish E; Dagen MM; Hart DM
    Maturitas; 1991 Dec; 14(1):33-42. PubMed ID: 1665197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on lipoproteins of Trisequens, a combined hormone preparation.
    Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
    Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
    Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women.
    Granfone A; Campos H; McNamara JR; Schaefer MM; Lamon-Fava S; Ordovas JM; Schaefer EJ
    Metabolism; 1992 Nov; 41(11):1193-8. PubMed ID: 1435290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
    Mattsson LA; Cullberg G; Samsioe G
    Acta Obstet Gynecol Scand; 1984; 63(8):673-7. PubMed ID: 6524301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women.
    Jensen J; Riis BJ; Strøm V; Christiansen C
    Br J Obstet Gynaecol; 1987 Feb; 94(2):130-5. PubMed ID: 3828253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study.
    Campos H; Wilson PW; Jiménez D; McNamara JR; Ordovas J; Schaefer EJ
    Metabolism; 1990 Oct; 39(10):1033-8. PubMed ID: 2120547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF
    Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
    Jensen J; Nilas L; Christiansen C
    Br J Obstet Gynaecol; 1986 Jun; 93(6):613-8. PubMed ID: 3730329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Jensen J; Riis BJ; Strøm V; Christiansen C
    Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women.
    Fletcher CD; Farish E; Dagen MM; Alazzawi F; McQueen D; Hart DM
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):339-42. PubMed ID: 2837887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.
    van der Mooren MJ; Demacker PN; Thomas CM; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):153-60. PubMed ID: 1459329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
    Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
    Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women.
    Kuller LH; Gutai JP; Meilahn E; Matthews KA; Plantinga P
    Arteriosclerosis; 1990; 10(6):1058-66. PubMed ID: 2123088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
    Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
    Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.